Skip to content
DataLookout
Menu

Pharmazz, Inc. clinical trial pipeline

Get alerts when Pharmazz, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: RESPECT-ETB · Sovateltide · Acute Cerebral Ischemic Stroke Trial sites expanded: 54 → 57 locations Pharmazz, Inc.Phase 3 NCT05691244
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 2
3
Phase 3
3
Phase 4
2

Disease areas by active trials

Get alerts when Pharmazz, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free